Kim Byung Gyu, Kachel Mateusz, Kim Jung-Sun, Guagliumi Giulio, Kim Choongki, Kim In-Soo, Lee Yong-Joon, Lee Oh-Hyun, Byun Young Sup, Kim Byung Ok, Milewski Krzysztof, Lee Seung-Jun, Hong Sung-Jin, Ahn Chul-Min, Shin Dong-Ho, Kim Byeong-Keuk, Ko Young-Guk, Choi Donghoon, Jang Yangsoo
Division of Cardiology, Department of Internal Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.
Center for Cardiovascular Research and Development, American Heart of Poland, Katowice, Poland; Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.
JACC Cardiovasc Imaging. 2022 Jan;15(1):126-137. doi: 10.1016/j.jcmg.2021.03.008. Epub 2021 May 19.
This study sought to evaluate the impact of poststent optical coherence tomography (OCT) findings, including severe malapposition, on long-term clinical outcomes.
Suboptimal OCT findings following percutaneous coronary intervention (PCI) are highly prevalent; however, their clinical implications remain controversial.
Of the patients registered in the Yonsei OCT registry, a total of 1,290 patients with 1,348 lesions, who underwent OCT immediately poststenting, were consecutively enrolled for this study. All patients underwent implantation of drug-eluting stents. Poststent OCT findings were assessed to identify predictors of device-oriented clinical endpoints (DoCE), including cardiac death, target vessel-related myocardial infarction (MI) or stent thrombosis, and target lesion revascularization (TLR). Significant malapposition criteria associated with major safety events (MSE) were also investigated, such as cardiac death, target vessel-related MI, or stent thrombosis.
The median follow-up period was 43.0 months (interquartile range [IQR] 21.4 to 56.0 months). The incidence rates of stent edge dissection, tissue prolapse, thrombus, and malapposition after intervention were not associated with occurrence of DoCE. However, patients with significant malapposition (total malapposition volume [TMV] ≥7.0 mm] exhibited more frequent MSE. A smaller minimal stent area (MSA) was identified as an independent predictor for DoCE (hazard ratio [HR]: 1.20 [95% confidence interval [CI]: 1.00 to 1.43]; p = 0.045). Malapposition with TMV ≥7.0 mm was found to be an independent predictor of MSE (HR: 6.12 [95% CI: 1.88 to 19.95]; p = 0.003). Follow-up OCT at 3, 6, or 9 months after PCI showed that poststent TMV ≥7.0 mm was related to a greater occurrence of late malapposition and uncovered struts.
Although most suboptimal OCT findings were not associated with clinical outcomes, a smaller MSA was associated with DoCE, driven mainly by TLR, and significant malapposition with TMV ≥7.0 mm was associated with more MSE after PCI. (Yonsei OCT [Optical Coherence Tomography] Registry for Evaluation of Efficacy and Safety of Coronary Stenting; Yonsei OCT registry; NCT02099162).
本研究旨在评估支架置入术后光学相干断层扫描(OCT)结果(包括严重贴壁不良)对长期临床结局的影响。
经皮冠状动脉介入治疗(PCI)后OCT结果欠佳的情况非常普遍;然而,其临床意义仍存在争议。
在延世OCT注册研究中登记的患者中,共有1290例患者、1348处病变在支架置入后立即接受了OCT检查,并连续纳入本研究。所有患者均接受了药物洗脱支架植入。评估支架置入术后OCT结果,以确定器械相关临床终点(DoCE)的预测因素,包括心源性死亡、靶血管相关心肌梗死(MI)或支架血栓形成以及靶病变血运重建(TLR)。还研究了与主要安全事件(MSE)相关的显著贴壁不良标准,如心源性死亡、靶血管相关MI或支架血栓形成。
中位随访期为43.0个月(四分位间距[IQR]21.4至56.0个月)。干预后支架边缘夹层、组织脱垂、血栓和贴壁不良的发生率与DoCE的发生无关。然而,显著贴壁不良(总贴壁不良体积[TMV]≥7.0mm)的患者发生MSE的频率更高。较小的心内膜下最小支架面积(MSA)被确定为DoCE的独立预测因素(风险比[HR]:1.20[95%置信区间[CI]:1.00至1.43];p = 0.045)。TMV≥7.0mm的贴壁不良被发现是MSE的独立预测因素(HR:6.12[95%CI:1.88至19.95];p = 0.003)。PCI后3、6或9个月的随访OCT显示,支架置入后TMV≥7.0mm与晚期贴壁不良和裸金属支架的发生率更高有关。
尽管大多数欠佳的OCT结果与临床结局无关,但较小的MSA与DoCE相关,主要由TLR驱动,且TMV≥7.0mm的显著贴壁不良与PCI后更多的MSE相关。(延世冠状动脉支架置入术疗效和安全性评估的OCT[光学相干断层扫描]注册研究;延世OCT注册研究;NCT02099162)